Item request has been placed!
×
Item request cannot be made.
×
Processing Request
진행성 암환자에서 완화적 항암치료 중단 시점의 결정에 대한 증례보고와 문헌고찰 (Korean)
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: 정 윤 진; 김 도 연
- المصدر:
Korean Journal of Hospice & Palliative Care; Mar2016, Vol. 19 Issue 1, p70-75, 6p
- الموضوع:
- معلومة اضافية
- Alternate Title:
Cases and Literature Review of Timing for Withdrawal of Palliative Chemotherapy. (English)
- الموضوع:
- نبذة مختصرة :
Advanced incurable cancer patients receive palliative chemotherapy to prolong their life and improve quality of life. However, physicians should assess the timing to discontinue the treatment, especially near the final months of life, as palliative chemotherapy may accompany considerable toxicity. Even though there are no clear guidelines regarding the withdrawal timing for anticancer treatment in palliative setting, it is important clarify the issue for quality of care for advanced cancer patients. Here, we present two patients who received palliative chemotherapy for advanced colon cancer and non-small cell lung cancer, respectively. In both cases, it was jointly determined to stop palliative chemotherapy, and best efforts are made to relieve troublesome symptoms. The cases and upto-date literature review will highlight the importance of the timing of discontinuation of cancer treatments when changes are being made to the health care system and hospice and palliative medicine is taking root in Korea. [ABSTRACT FROM AUTHOR]
- نبذة مختصرة :
Copyright of Korean Journal of Hospice & Palliative Care is the property of Korean Society for Hospice & Palliative Care and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.